↑ Clough, C.G.; Plaitakis, A. and Yahr, M.D. (1983) Full Text Arch. Neurol. 40 (1) 36 - 37. Oculogyric crises and parkinsonism. A case of recent onset.http://www.ncbi.nlm.nih.gov/pubmed/6848086
↑ Furumoto,H; Kitano, K; Wang, d.s.; Matumoto, S. and Moroo (1989) Full Text Rinsho Shinkeigaku 29 (10) 1287 – 1298 Oculogyric crisis as an initial symptom of juvenile parkinsonism-like disease http://www.ncbi.nlm.nih.gov/pubmed/2605835
↑Wilkaniec, A; Stosznajder,J.B. and Adamczyk, A. (2013) Full Text Neurochem. Int. 14. pii: S0197-0186(13)00043-0. Toxicity of extracellular secreted alpha-synuclein: Its role in nitrosative stress and neurodegenerationhttp://www.ncbi.nlm.nih.gov/pubmed/23416621
Olfactory dysfunction (A reduced or impaired ability to detect odours)
Hoyles and Sharma (2013) Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach[1]
Takeda (2013) Severe olfactory dysfunction is a predictor of dementia with Parkinson’s disease[2]
Hüttenbrink et al (2013) Olfactory dysfunction: common in later life and early warning of neurodegenerative disease [3]
Further Research
Search the scientific literature
Literature search:
Use the following links to query the PubMed, PubMed Central and Google Scholar databases using the Search terms:- Parkinson's_Disease Olfactory_dysfunction.
This will list the latest papers on this topic. You are invited to update this page to reflect such recent results, pointing out their significance.
↑Hoyles, K. and Shama, (2013)Full Text
J.C. J. Neurol. (Feb. 3) Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach. http://www.ncbi.nlm.nih.gov/pubmed/23377435
↑ Takeda,A. (2013)Full Text Rinsho Shinkeigaku 53 (2) 91 – 97 Severe olfactory dysfunction is a predictor of dementia with Parkinson’s diseasehttp://www.ncbi.nlm.nih.gov/pubmed/23470887
↑ Hüttenbrink. K.B.; Hummel.T.; Berg, D; Gasser, T. and Hähner,A. (2013)Full TextDtsch. Arztebl. Int. 110 (1-2) 1 – 7 Olfactory dysfunction: common in later life and early warning of neurodegenerative disease http://www.ncbi.nlm.nih.gov/pubmed/23450985
Use the following links to query the PubMed, PubMed Central and Google Scholar databases using the Search terms:- Parkinson's_Disease Motor_fluctuations.
This will list the latest papers on this topic. You are invited to update this page to reflect such recent results, pointing out their significance.
↑ Bordelon, Yvett;M.; Hayes, Ron D,; Vassar, Stefanie D.; Diaz, Natalie; Bronstein, Jeff and Vickrey, Barbra, G. (2011) Full Text Parkinsons Dis. 2001 967839 Medication Responsiveness of Motor Symptoms in a Population-Based Study of Parkinson Diseasehttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236449
↑ Bohnen, Nicolaas I.; Muller, Martijn L.T.M.; Zarzhevsky, Natalia; Koeppe, Robert A.; Bogan, Christopher W.; Kilbourn, Michael R.; Frey, Kirk A. and Albin, Roger L.(2011) Full Text Brain 134 (8) 2358 – 2365 Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson’s disease http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155702/
↑ Mera, Thomas O.; Heldman, Dustin (2012) Full Text J. Neurosci. Methods 203 (1) 152 – 156. Feasibility of home-based automated Parkinson’s disease motor assessment http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221741/
Guiloff et al (1980)Reversible supranuclear ophthalmoplegia associated with Parkinsonism [1]
Armstrong (2011)Visual signs and symptoms of progressive supranuclear palsy. [2]
Pontieri et al (2012) Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease[3]Further Research
Search the scientific literature
Literature search:
Use the following links to query the PubMed, PubMed Central and Google Scholar databases using the Search terms:- Parkinson's_Disease Ophthalmoplegia.
This will list the latest papers on this topic. You are invited to update this page to reflect such recent results, pointing out their significance.
Drop in blood pressure during changes in body position.
A recent review of Cardiovascular dysautonomia in Parkinson's by Jain and Goldstein (2012)
is particularly relevant.[1]
The following references are also relevant:-
Hussain et al (2001) Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension [2]
Park and Stacy(2011) Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease [3]
Sommer et al (2011) Nondipping in Parkinson's Disease [4]
Further Research
Search the scientific literature
Literature search:
Use the following links to query the PubMed, PubMed Central and Google Scholar databases using the Search terms:- Parkinson's_Disease Orthostatic_hypotension.
This will list the latest papers on this topic. You are invited to update this page to reflect such recent results, pointing out their significance.
↑Jain, Samay, and David S. Goldstein. Cardiovascular Dysautonomia in Parkinson Disease: From Pathophysiology to Pathogenesis. Neurobiology of Disease 46, no. 3 (June 2012): 572–580. Full Text PubMed Central http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299874/
↑ Husain, I.; Brady, C.; Swinn, M.; Mathias, C. and Fowler, C. (2001)Full TextJ. Neurol. Neurosurg. Psychiatry. 71 (3) 371 – 374 Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1737541/